Top 10 Articles on Psychedelics and Integration

This paper gives clinicians a practical model for psychedelic harm reduction and integration. PHRI is useful because it meets clients where they are: preparing for psychedelic use, making sense of difficult or meaningful experiences, and reducing risk without relying on abstinence-only assumptions.

This early LSD-assisted psychotherapy study shows that integration was part of psychedelic care well before the modern revival. The post-session interviews helped patients with cancer relate the experience back to everyday life, mortality, and emotional distress.

Sloshower and colleagues connect psilocybin therapy for depression with Acceptance and Commitment Therapy. The paper is useful because it turns broad ideas like openness and insight into a therapeutic frame focused on values, acceptance, and committed action.

Watts and Luoma translate psychological flexibility into the ACE model: Accept, Connect, Embody. The paper matters because it gives therapists a concrete integration structure for helping psychedelic experiences become changes in behaviour and outlook.

Johnson and colleagues set out practical safety principles for human psychedelic research, including screening, preparation, support, and setting. Those safeguards are also foundational for integration, because difficult material is easier to work with inside a trusted therapeutic container.

Bogenschutz and Forcehimes describe a therapy model tailored to psilocybin-assisted treatment for alcohol use disorder. It is valuable because it shows how integration can be adapted to a specific indication, helping patients connect the session to motivation and drinking behaviour.

This large survey of difficult psilocybin experiences shows why integration cannot focus only on positive insights. Many respondents reported later benefits, but some also faced acute or lasting distress, underscoring the need for support before, during, and after challenging experiences.

Gandy and colleagues argue that nature contact may strengthen the therapeutic effects of psychedelic care. The paper is speculative, but useful for integration because it broadens the setting beyond the clinic and asks how environment can support mental health change.

Heuschkel and Kuypers compare mindfulness meditation and psilocybin as potentially complementary approaches for depression. The review is helpful because it frames mindfulness as a way to continue practising attention, acceptance, and perspective-taking after a psychedelic session.

Pilecki and colleagues address the legal and ethical realities therapists face when clients use psychedelics outside approved medical contexts. The paper is important because it shows how integration can reduce harm while keeping clinical boundaries clear.